Search Results - "Tamai, Yoshiko"

Refine Results
  1. 1

    Appropriate use of blood components by Tamai, Yoshiko

    Published in Rinshō ketsueki (2024)
    “…Blood products are biological products derived from human blood. Japan currently meets its domestic needs with red cell products, platelet products, and plasma…”
    Get more information
    Journal Article
  2. 2

    Transfusion-Related Alloimmunization to Red Blood Cell Antigens in Japanese Pediatric Recipients by Tamai, Yoshiko, Ohto, Hitoshi, Takahashi, Hideto, Kitazawa, Junichi

    Published in Transfusion medicine reviews (01-01-2021)
    “…Red blood cell (RBC) transfusion to neonates is thought to rarely provoke an immune response. Neonatal testing guidelines suggest that antibody screening is…”
    Get full text
    Journal Article
  3. 3

    Clotting functional stability of withdrawing blood in storage for acute normovolemic hemodilution: a pilot study by Kinoshita, Hirotaka, Saito, Junichi, Nakai, Kishiko, Noguchi, Satoko, Takekawa, Daiki, Tamai, Yoshiko, Kitayama, Masato, Hirota, Kazuyoshi

    Published in Journal of anesthesia (01-02-2021)
    “…Purpose This study was conducted to time-course changes of clotting function of withdrawing blood for acute normovolemic hemodilution (ANH). Methods Twelve…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The efficacy of acute normovolemic hemodilution for preventing perioperative allogeneic blood transfusion in gynecological cancer patients by Saito, Junichi, Masui, Kenichi, Noguchi, Satoko, Nakai, Kishiko, Tamai, Yoshiko, Midorikawa, Yoko, Kinoshita, Hirotaka, Mikami, Noriko, Kitayama, Masato, Hashimoto, Hiroshi, Hirota, Kazuyoshi

    Published in Journal of clinical anesthesia (01-03-2020)
    “…The data were obtained from 708 patients, of whom 122 patients were excluded from the analysis due to pre-operative ABT received within 3 days before surgery…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability by Kadirvel, Senkottuvelan, Furuyama, Kazumichi, Harigae, Hideo, Kaneko, Kiriko, Tamai, Yoshiko, Ishida, Yoji, Shibahara, Shigeki

    Published in Experimental hematology (01-06-2012)
    “…Erythroid-specific 5-aminolevulinate synthase (ALAS2) is essential for hemoglobin production, and a loss-of-function mutation of ALAS2 gene causes X-linked…”
    Get full text
    Journal Article
  10. 10

    A case report of sudden thrombocytopenia detected only by in vitro analysis by Noguchi, Satoko, Kitayama, Masato, Niwa, Hidetomo, Tamai, Yoshiko, Hirota, Kazuyoshi

    Published in Journal of anesthesia (01-08-2016)
    “…We experienced an unexpected thrombocytopenia detected only in vitro during radical prostatectomy for a 66-year-old patient. Thrombocytopenia with platelet…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures by Komatsu, Tomoko, Tamai, Yoshiko, Takami, Hideki, Yamagata, Kazufumi, Fukuda, Shinsaku, Munakata, Akihiro

    Published in Journal of gastroenterology (01-07-2005)
    “…Anti-platelet agents are widely used for the treatment and prevention of thrombotic diseases. On the other hand, continuation of anti-platelet agents increases…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Strategy for identification of sequence variants in COL7A1 and a novel 2-bp deletion mutation in recessive dystrophic epidermolysis bullosa by Christiano, Angela M., Hoffman, Guy G., Zhang, Xin, Xu, Yili, Tamai, Yoshiko, Greenspan, Daniel S., Uitto, Jouni

    Published in Human mutation (1997)
    “…The diagnostic hallmark of the dystrophic forms of epidermolysis bullosa (DEB), a group of heritable blistering skin diseases, is abnormalities in the…”
    Get full text
    Journal Article
  15. 15

    MANAGEMENT OF ANTIPLATELET THERAPY FOR ENDOSCOPIC PROCEDURES: OPTIMAL CESSATION PERIOD OF ANTIPLATELET THERAPY FOR JAPANESE by Tamai, Yoshiko, Komatsu-Ishizawa, Tomoko, Takami, Hideki, Nakajima, Hitoshi, Fukuda, Shinsaku, Munakata, Akihiro

    Published in Digestive endoscopy (01-10-2007)
    “…Although antiplatelet agents are widely used for the treatment and prevention of thrombotic diseases, only a few studies have reported the validity of the…”
    Get full text
    Journal Article
  16. 16

    Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination by Tachita, Takuto, Takahata, Takenori, Yamashita, Satoru, Ebina, Toru, Kamata, Kosuke, Yamagata, Kazufumi, Tamai, Yoshiko, Sakuraba, Hirotake

    Published in International journal of hematology (01-10-2023)
    “…Anti-SARS-CoV-2 vaccines were developed in response to the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Thrombocytopenia caused by platelet destruction, consumption or abnormal pooling by Tamai, Yoshiko, Takami, Hideki

    Published in Nihon rinshō (01-04-2003)
    “…In this article, we refer to thrombocytopenia caused by increased destruction/consumption of platelets(immune thrombocytopenia and non-immune…”
    Get more information
    Journal Article
  20. 20